Hikma Pharmaceuticals PLC (LON:HIK)
London · Delayed Price · Currency is GBP · Price in GBX 1,585.00
-9.00 (-0.56%)
Jul 31, 2026, 5:13 PM GMT
Hikma Pharmaceuticals Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,334 | 3,412 | 4,393 | 3,958 | 3,419 | 5,137 | |
Market Cap Growth | -24.18% | -22.34% | 10.99% | 15.76% | -33.43% | -11.48% |
Enterprise Value | 4,355 | 4,453 | 5,293 | 4,741 | 4,268 | 5,458 |
Last Close Price | 15.85 | 15.50 | 19.93 | 17.90 | 15.53 | 22.19 |
PE Ratio | 11.79 | 11.52 | 15.53 | 26.81 | 22.36 | 16.60 |
Forward PE | 9.62 | 8.95 | 10.90 | 10.80 | 9.65 | 14.20 |
PEG Ratio | 1.46 | 1.24 | 1.66 | 1.55 | 2.10 | 1.49 |
PS Ratio | 1.34 | 1.37 | 1.76 | 1.75 | 1.64 | 2.72 |
PB Ratio | 1.72 | 1.77 | 2.39 | 2.29 | 1.94 | 2.83 |
P/TBV Ratio | 2.48 | 2.43 | 3.86 | 3.63 | 3.45 | 3.31 |
P/FCF Ratio | 18.78 | 19.20 | 13.82 | 11.48 | 10.55 | 14.09 |
P/OCF Ratio | 10.29 | 10.52 | 9.77 | 8.29 | 7.81 | 10.89 |
EV/Sales Ratio | 1.75 | 1.79 | 2.12 | 2.10 | 2.05 | 2.89 |
EV/EBITDA Ratio | 6.62 | 7.68 | 8.51 | 9.64 | 7.89 | 10.15 |
EV/EBIT Ratio | 10.83 | 11.05 | 10.85 | 16.45 | 18.31 | 12.68 |
EV/FCF Ratio | 24.53 | 25.05 | 16.65 | 13.75 | 13.17 | 14.97 |
Debt / Equity Ratio | 0.57 | 0.57 | 0.28 | 0.47 | 0.53 | 0.29 |
Debt / EBITDA Ratio | 1.81 | 2.06 | 1.67 | 1.90 | 1.96 | 1.16 |
Debt / FCF Ratio | 6.71 | 6.71 | 3.27 | 2.71 | 3.27 | 1.72 |
Net Debt / Equity Ratio | 0.54 | 0.54 | 0.48 | 0.45 | 0.47 | 0.17 |
Net Debt / EBITDA Ratio | 1.56 | 1.78 | 1.43 | 1.58 | 1.55 | 0.58 |
Net Debt / FCF Ratio | 5.80 | 5.80 | 2.80 | 2.25 | 2.58 | 0.85 |
Asset Turnover | 0.62 | 0.62 | 0.64 | 0.63 | 0.57 | 0.60 |
Inventory Turnover | 1.82 | 1.82 | 1.82 | 1.78 | 1.74 | 1.72 |
Quick Ratio | 0.89 | 0.89 | 0.59 | 0.81 | 1.03 | 1.28 |
Current Ratio | 1.82 | 1.82 | 1.14 | 1.57 | 1.86 | 2.06 |
Return on Equity (ROE) | 16.52% | 16.52% | 15.98% | 8.81% | 8.28% | 18.20% |
Return on Assets (ROA) | 7.87% | 7.87% | 9.92% | 5.48% | 5.23% | 10.56% |
Return on Invested Capital (ROIC) | 10.64% | 11.44% | 14.68% | 7.89% | 7.64% | 15.92% |
Return on Capital Employed (ROCE) | 14.70% | 14.70% | 18.84% | 10.90% | 8.36% | 18.01% |
Earnings Yield | 8.96% | 8.68% | 6.44% | 3.73% | 4.47% | 6.02% |
FCF Yield | 5.33% | 5.21% | 7.24% | 8.71% | 9.48% | 7.10% |
Dividend Yield | 3.94% | 4.02% | 3.16% | 2.72% | 2.97% | 1.73% |
Payout Ratio | 46.02% | 46.02% | 48.75% | 72.11% | 66.49% | 28.50% |
Buyback Yield / Dilution | 0.36% | 0.36% | -0.51% | 1.13% | 3.47% | 2.10% |
Total Shareholder Return | 4.30% | 4.39% | 2.66% | 3.85% | 6.45% | 3.83% |